SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-18-022544
Filing Date
2018-12-21
Accepted
2018-12-21 17:28:25
Documents
10
Period of Report
2018-12-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K wint20181221_8k.htm 8-K 49796
2 EXHIBIT 4.1 ex_132015.htm EX-4.1 44580
3 EXHIBIT 4.2 ex_132016.htm EX-4.2 81003
4 EXHIBIT 4.3 ex_132017.htm EX-4.3 80246
5 EXHIBIT 10.1 ex_132018.htm EX-10.1 501649
6 EXHIBIT 10.2 ex_132019.htm EX-10.2 45768
7 EXHIBIT 10.3 ex_132077.htm EX-10.3 132933
8 EXHIBIT 10.4 ex_132076.htm EX-10.4 137786
9 EXHIBIT 99.1 ex_132081.htm EX-99.1 31650
10 logo.jpg GRAPHIC 11955
  Complete submission text file 0001437749-18-022544.txt   1123811
Mailing Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976
Business Address 2600 KELLY ROAD SUITE 100 WARRINGTON PA 18976 2154889300
WINDTREE THERAPEUTICS INC /DE/ (Filer) CIK: 0000946486 (see all company filings)

IRS No.: 943171943 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26422 | Film No.: 181250595
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1